loadpatents
name:-0.04047703742981
name:-0.024393081665039
name:-0.00074291229248047
Marlow; Allison L. Patent Filings

Marlow; Allison L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Marlow; Allison L..The latest application filed is for "serine/threonine kinase inhibitors".

Company Profile
0.28.38
  • Marlow; Allison L. - Boulder CO
  • Marlow; Allison L. - Louisville CO US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Serine/threonine kinase inhibitors
Grant 9,133,187 - Blake , et al. September 15, 2
2015-09-15
Serine/threonine Kinase Inhibitors
App 20130338140 - Blake; James F. ;   et al.
2013-12-19
Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal
Grant 8,513,293 - Wallace , et al. August 20, 2
2013-08-20
Heterocyclic Inhibitors Of Mek And Methods Of Use Thereof
App 20130018075 - Marlow; Allison L. ;   et al.
2013-01-17
Methods of Treating a Hyperproliferative Disorder or Inhibiting Cell Growth in a Mammal
App 20120277277 - Wallace; Eli M. ;   et al.
2012-11-01
Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6- -dihydropyridine-3-carboxamide
Grant 8,299,076 - Marlow , et al. October 30, 2
2012-10-30
Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof
App 20120263679 - Marlow; Allison L. ;   et al.
2012-10-18
6-oxo-1,6-dihydropyridine derivatives as inhibitors of MEK and methods of use thereof
Grant 8,211,920 - Marlow , et al. July 3, 2
2012-07-03
Heterocyclic inhibitors of MEK and methods of use
Grant 8,211,921 - Blake , et al. July 3, 2
2012-07-03
Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
Grant 8,193,229 - Wallace , et al. June 5, 2
2012-06-05
Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
Grant 8,193,231 - Wallace , et al. June 5, 2
2012-06-05
Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
Grant 8,193,230 - Wallace , et al. June 5, 2
2012-06-05
N3 alkylated benzimidazole derivatives as MEK inhibitors
Grant 8,178,693 - Wallace , et al. May 15, 2
2012-05-15
6-oxo-1,6-dihydropyridine compounds as inhibitors of MEK and methods of use thereof
Grant 8,101,639 - Marlow , et al. January 24, 2
2012-01-24
Substituted pyridazines inhibitors of MEK
Grant 8,101,611 - Marlow , et al. January 24, 2
2012-01-24
Heterocyclic Inhibitors of MEK and Methods of Use Thereof
App 20110288092 - Marlow; Allison L. ;   et al.
2011-11-24
Heterobicyclic thiophene compounds and methods of use
Grant 8,003,662 - Blake , et al. August 23, 2
2011-08-23
N3 alkylated benzimidazole derivatives as MEK inhibitors
Grant 8,003,805 - Wallace , et al. August 23, 2
2011-08-23
Heterocyclic Inhibitors Of Mek And Methods Of Use Thereof
App 20110183981 - Marlow; Allison L. ;   et al.
2011-07-28
Heterocyclic Inhibitors Of Mek And Methods Of Use Thereof
App 20110178136 - Marlow; Allison L. ;   et al.
2011-07-21
N3 alkylated benzimidazole derivatives as MEK inhibitors
Grant 7,973,170 - Wallace , et al. July 5, 2
2011-07-05
Compositions Comprising N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors And Methods Of Use Thereof
App 20110158971 - Wallace; Eli M. ;   et al.
2011-06-30
Quinoline Compounds And Methods Of Use
App 20110053931 - Gaudino; John ;   et al.
2011-03-03
Heterocyclic inhibitors of MEK and methods of use thereof
Grant 7,893,065 - Marlow , et al. February 22, 2
2011-02-22
N3 alkylated benzimidazole derivatives as MEK inhibitors
Grant 7,842,816 - Wallace , et al. November 30, 2
2010-11-30
N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
App 20100267710 - Wallace; Eli M. ;   et al.
2010-10-21
Method Of Treatment Using N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
App 20100267793 - Wallace; Eli M. ;   et al.
2010-10-21
Compositions Comprising N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors And Methods Of Use Thereof
App 20100260714 - Wallace; Eli M. ;   et al.
2010-10-14
N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
App 20100261718 - Wallace; Eli M. ;   et al.
2010-10-14
N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
App 20100261717 - Wallace; Eli M. ;   et al.
2010-10-14
Heterobicyclic Pyrazole Compounds And Methods Of Use
App 20100256356 - Blake; James F. ;   et al.
2010-10-07
N3 alkylated benzimidazole derivatives as MEK inhibitors
Grant 7,777,050 - Wallace , et al. August 17, 2
2010-08-17
Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
Grant 7,732,616 - Marlow , et al. June 8, 2
2010-06-08
Heterobicyclic pyrazole compounds and methods of use
Grant 7,723,330 - Blake , et al. May 25, 2
2010-05-25
Heterocyclic Inhibitors Of Mek And Methods Of Use Thereof
App 20100063053 - Marlow; Allison L. ;   et al.
2010-03-11
Heterocyclic inhibitors of MEK and methods of use thereof
Grant 7,598,383 - Marlow , et al. October 6, 2
2009-10-06
Heterocyclic Inhibitors Of Mek And Methods Of Use Thereof
App 20090215834 - Marlow; Allison L. ;   et al.
2009-08-27
Heterocyclic Inhibitors Of Mek And Methods Of Use Thereof
App 20090209542 - Marlow; Allison L. ;   et al.
2009-08-20
N3 alkylated benzimidazole derivatives as MEK inhibitors
Grant 7,576,114 - Wallace , et al. August 18, 2
2009-08-18
Heterocyclic inhibitors of MEK and methods of use thereof
Grant 7,576,072 - Wallace , et al. August 18, 2
2009-08-18
Method of treating inflammatory diseases
Grant 7,538,120 - Koch , et al. May 26, 2
2009-05-26
Heterocyclic Inhibitors Of Mek And Methods Of Use
App 20090131435 - Marlow; Allison L. ;   et al.
2009-05-21
Heterocyclic inhibitors of MEK and methods of use thereof
Grant 7,517,994 - Marlow , et al. April 14, 2
2009-04-14
Heterocyclic Inhibitors of Mek and Methods of Use Thereof
App 20080280957 - Marlow; Allison L. ;   et al.
2008-11-13
N3 alkylated benzimidazole derivatives as MEK inhibitors
Grant 7,425,637 - Wallace , et al. September 16, 2
2008-09-16
N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
App 20080177082 - Wallace; Eli M. ;   et al.
2008-07-24
N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
App 20080171778 - WALLACE; Eli M. ;   et al.
2008-07-17
N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
App 20070299063 - Wallace; Eli M. ;   et al.
2007-12-27
Heterobicyclic pyrazole compounds and methods of use
App 20070238726 - Blake; James F. ;   et al.
2007-10-11
Heterobicyclic thiophene compounds and methods of use
App 20070197537 - Blake; James F. ;   et al.
2007-08-23
N3 alkylated benzimidazole derivatives as MEK inhibitors
Grant 7,235,537 - Wallace , et al. June 26, 2
2007-06-26
Heterocyclic inhibitors of MEK and methods of use thereof
App 20070112038 - Marlow; Allison L. ;   et al.
2007-05-17
N3 alkylated benzimidazole derivatives as MEK inhibitors
App 20060106225 - Wallace; Eli M. ;   et al.
2006-05-18
Method of treating inflammatory diseases
App 20060030610 - Koch; Kevin ;   et al.
2006-02-09
Heterocyclic inhibitors of MEK and methods of use thereof
App 20050256123 - Marlow, Allison L. ;   et al.
2005-11-17
Heterocyclic inhibitors of MEK and methods of use thereof
App 20050250782 - Marlow, Allison L. ;   et al.
2005-11-10
Heterocyclic inhibitors of MEK and methods of use thereof
App 20050153942 - Wallace, Eli ;   et al.
2005-07-14
N3 alkylated benzimidazole derivatives as MEk inhibitors
App 20050143438 - Wallace, Eli M. ;   et al.
2005-06-30
Heterocyclic inhibitors of MEK and methods of use thereof
App 20050054701 - Wallace, Eli ;   et al.
2005-03-10
N3 alkylated benzimidazole derivatives as MEK inhibitors
App 20040116710 - Wallace, Eli M. ;   et al.
2004-06-17
N3 alkylated benzimidazole derivatives as MEK inhibitors
App 20030232869 - Wallace, Eli M. ;   et al.
2003-12-18
N3 alkylated benzimidazole derivatives as MEK inhibitors
App 20030216460 - Wallace, Eli M. ;   et al.
2003-11-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed